Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CleSenz (officially Clesens ApS) is a Danish biotechnology company specializing in the development of genetically encoded biosensors for the real-time monitoring of small molecules and metabolites. Spun out from the Technical University of Denmark (DTU) and the Novo Nordisk Foundation Center for Biosustainability, the company provides a platform that enables high-throughput screening and precise control of fermentation processes in biomanufacturing. By providing immediate feedback on metabolite concentrations, CleSenz helps optimize production yields and reduce costs for the bio-based industry. While its primary focus is currently on industrial biotechnology and strain development, the technology has significant potential for applications in clinical diagnostics and personalized health monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clesens.